Sign in
BWV Stock Price, Chart, Stats & News
Blue Water Vaccines, Inc.
Save
3.41M
Market cap
–
Current P/E
–
Forward P/E
BWV chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 77.62% |
Operating margin | -2190.03% |
Pretax margin | -1720.91% |
Net margin | -1720.98% |
Effective tax rate | 0.00% |
ROA | -56.29% |
ROE | -193.27% |
D/E | 0.00x |
Interest coverage ratio | 23.78x |
BWV valuation
P/E | – |
P/S | 4.18x |
P/B | 0.01x |
P/CF | -0.02x |
P/FCF | -0.35x |
P/OCF | -0.02x |
PEG | -0.00x |
EV multiple | -0.48x |
About
Blue Water Vaccines, Inc. (BWV) operates as a biotechnology firm dedicated to the worldwide discovery and development of vaccines aimed at preventing infectious diseases. Currently in preclinical stages, their most prominent vaccine candidates are BWV-101, an influenza shot, and BWV-102, designed to counter H1 pre-pandemic threats. The company's developmental portfolio also includes other preclinical programs such as BWV-201, a vaccine addressing acute otitis media caused by Streptococcus pneumoniae; BWV-301, a combined vaccine for norovirus and rotavirus; and BWV-302, a dual-target vaccine for norovirus and malaria.
Similar securities
Based on sector and market capitalization
Report issue